LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients

by Giulia Wanka, Elisa Schmoeckel, Doris Mayr, Sophie Fuerst, Christina Kuhn, Sven Mahner, Julia Knabl, Maria Margarete Karsten, Christian Dannecker, Helene H. Heidegger, Aurelia Vattai, Udo Jeschke, Julia Jueckstock
Published 2020-12-01

PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised con...

by Maria Margarete Karsten, Friedrich Kühn, Therese Pross, Jens-Uwe Blohmer, Anna Maria Hage, Felix Fischer, Matthias Rose, Ulrike Grittner, Pimrapat Gebert, Julia Ferencz, Luis Pauler, Clara Breidenbach, Christoph Kowalski, on behalf of the PRO B Steering Board
Published 2021-09-01

RESPONDER – diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-in...

by Joerg Heil, Peter Sinn, Hannah Richter, André Pfob, Benedikt Schaefgen, André Hennigs, Fabian Riedel, Bettina Thomas, Marc Thill, Markus Hahn, Jens-Uwe Blohmer, Sherko Kuemmel, Maria Margarete Karsten, Mattea Reinisch, John Hackmann, Toralf Reimer, Geraldine Rauch, Michael Golatta
Published 2018-08-01